603718 Stock Overview
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Shanghai Hile Bio-Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.08 |
| 52 Week High | CN¥11.87 |
| 52 Week Low | CN¥6.00 |
| Beta | 1.05 |
| 1 Month Change | -13.40% |
| 3 Month Change | -11.01% |
| 1 Year Change | -22.83% |
| 3 Year Change | -53.40% |
| 5 Year Change | -45.18% |
| Change since IPO | 89.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603718 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.6% | 3.0% | 1.6% |
| 1Y | -22.8% | -12.9% | -15.1% |
Return vs Industry: 603718 underperformed the CN Pharmaceuticals industry which returned -12.9% over the past year.
Return vs Market: 603718 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 603718 volatility | |
|---|---|
| 603718 Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 603718 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603718's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 491 | James Chen | www.hile-bio.com |
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines.
Shanghai Hile Bio-Technology Co., Ltd. Fundamentals Summary
| 603718 fundamental statistics | |
|---|---|
| Market cap | CN¥5.32b |
| Earnings (TTM) | CN¥156.25m |
| Revenue (TTM) | CN¥222.19m |
34.0x
P/E Ratio23.9x
P/S RatioIs 603718 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603718 income statement (TTM) | |
|---|---|
| Revenue | CN¥222.19m |
| Cost of Revenue | CN¥109.51m |
| Gross Profit | CN¥112.68m |
| Other Expenses | -CN¥43.57m |
| Earnings | CN¥156.25m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 50.71% |
| Net Profit Margin | 70.32% |
| Debt/Equity Ratio | 27.4% |
How did 603718 perform over the long term?
See historical performance and comparison